annual CFI:
-$556.00K+$292.95M(+99.81%)Summary
- As of today (June 28, 2025), CPRX annual cash flow from investing activities is -$556.00 thousand, with the most recent change of +$292.95 million (+99.81%) on December 31, 2024.
- During the last 3 years, CPRX annual CFI has risen by +$10.46 million (+94.96%).
- CPRX annual CFI is now -101.49% below its all-time high of $37.23 million, reached on December 31, 2019.
Performance
CPRX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$0.00+$88.00K(+100.00%)Summary
- As of today (June 28, 2025), CPRX quarterly cash flow from investing activities is $0.00, with the most recent change of +$88.00 thousand (+100.00%) on March 31, 2025.
- Over the past year, CPRX quarterly CFI has increased by +$199.00 thousand (+100.00%).
- CPRX quarterly CFI is now -100.00% below its all-time high of $31.66 million, reached on December 31, 2019.
Performance
CPRX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$357.00K+$199.00K(+35.79%)Summary
- As of today (June 28, 2025), CPRX TTM cash flow from investing activities is -$357.00 thousand, with the most recent change of +$199.00 thousand (+35.79%) on March 31, 2025.
- Over the past year, CPRX TTM CFI has increased by +$130.98 million (+99.73%).
- CPRX TTM CFI is now -100.86% below its all-time high of $41.71 million, reached on June 30, 2020.
Performance
CPRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CPRX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.8% | +100.0% | +99.7% |
| 3 y3 years | +95.0% | 0.0% | +91.3% |
| 5 y5 years | -101.5% | -100.0% | -101.1% |
CPRX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.0% | +99.8% | -100.0% | +100.0% | -103.9% | +99.9% |
| 5 y | 5-year | -101.5% | +99.8% | -100.0% | +100.0% | -100.9% | +99.9% |
| alltime | all time | -101.5% | +99.8% | -100.0% | +100.0% | -100.9% | +99.9% |
CPRX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $0.00(-100.0%) | -$357.00K(-35.8%) |
| Dec 2024 | -$556.00K(-99.8%) | -$88.00K(-66.0%) | -$556.00K(-98.6%) |
| Sep 2024 | - | -$259.00K(+2490.0%) | -$38.79M(-70.5%) |
| Jun 2024 | - | -$10.00K(-95.0%) | -$131.34M(+0.0%) |
| Mar 2024 | - | -$199.00K(-99.5%) | -$131.33M(-55.3%) |
| Dec 2023 | -$293.50M(-3287.1%) | -$38.32M(-58.7%) | -$293.50M(+15.0%) |
| Sep 2023 | - | -$92.82M(<-9900.0%) | -$255.18M(+57.0%) |
| Jun 2023 | - | $0.00(-100.0%) | -$162.50M(+6.1%) |
| Mar 2023 | - | -$162.37M(<-9900.0%) | -$153.16M(-1763.1%) |
| Dec 2022 | $9.21M(-183.6%) | $0.00(-100.0%) | $9.21M(+0.4%) |
| Sep 2022 | - | -$132.00K(-101.4%) | $9.17M(-0.7%) |
| Jun 2022 | - | $9.34M(>+9900.0%) | $9.23M(-324.6%) |
| Mar 2022 | - | $0.00(-100.0%) | -$4.11M(-62.7%) |
| Dec 2021 | -$11.02M(+119.9%) | -$41.00K(-39.7%) | -$11.02M(+0.4%) |
| Sep 2021 | - | -$68.00K(-98.3%) | -$10.98M(-47.5%) |
| Jun 2021 | - | -$4.00M(-42.1%) | -$20.92M(+23.6%) |
| Mar 2021 | - | -$6.91M(<-9900.0%) | -$16.92M(+237.7%) |
| Dec 2020 | -$5.01M(-113.5%) | $0.00(-100.0%) | -$5.01M(-118.8%) |
| Sep 2020 | - | -$10.01M(<-9900.0%) | $26.65M(-36.1%) |
| Jun 2020 | - | $0.00(-100.0%) | $41.71M(+31.3%) |
| Mar 2020 | - | $5.00M(-84.2%) | $31.78M(-14.6%) |
| Dec 2019 | $37.23M(-346.8%) | $31.66M(+527.3%) | $37.23M(+88.9%) |
| Sep 2019 | - | $5.05M(-150.8%) | $19.71M(-11.4%) |
| Jun 2019 | - | -$9.93M(-195.0%) | $22.24M(-18.3%) |
| Mar 2019 | - | $10.45M(-26.1%) | $27.21M(-280.4%) |
| Dec 2018 | -$15.08M(>+9900.0%) | $14.14M(+86.7%) | -$15.08M(-48.3%) |
| Sep 2018 | - | $7.58M(-252.9%) | -$29.17M(-20.7%) |
| Jun 2018 | - | -$4.96M(-84.4%) | -$36.77M(+15.6%) |
| Mar 2018 | - | -$31.85M(<-9900.0%) | -$31.82M(>+9900.0%) |
| Dec 2017 | -$4000.00(-100.1%) | $60.80K(-304.0%) | -$3900.00(-100.7%) |
| Sep 2017 | - | -$29.80K(+1555.6%) | $521.80K(-81.0%) |
| Jun 2017 | - | -$1800.00(-94.6%) | $2.75M(-23.3%) |
| Mar 2017 | - | -$33.10K(-105.6%) | $3.59M(+0.9%) |
| Dec 2016 | $3.55M | $586.50K(-73.3%) | $3.55M(+17.8%) |
| Sep 2016 | - | $2.20M(+164.1%) | $3.02M(+290.1%) |
| Jun 2016 | - | $832.70K(-1369.4%) | $773.20K(-2784.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$65.60K(-229.9%) | -$28.80K(+343.1%) |
| Dec 2015 | -$6500.00(-99.9%) | $50.50K(-213.7%) | -$6500.00(-90.1%) |
| Sep 2015 | - | -$44.40K(-244.6%) | -$65.90K(+929.7%) |
| Jun 2015 | - | $30.70K(-170.9%) | -$6400.00(-99.9%) |
| Mar 2015 | - | -$43.30K(+386.5%) | -$10.05M(+15.0%) |
| Dec 2014 | -$8.74M(+16.6%) | -$8900.00(-158.9%) | -$8.74M(-43.7%) |
| Sep 2014 | - | $15.10K(-100.2%) | -$15.54M(-21.3%) |
| Jun 2014 | - | -$10.01M(-891.5%) | -$19.75M(+155.9%) |
| Mar 2014 | - | $1.26M(-118.6%) | -$7.72M(+2.9%) |
| Dec 2013 | -$7.50M(-46.7%) | -$6.81M(+62.2%) | -$7.50M(-49.2%) |
| Sep 2013 | - | -$4.20M(-307.6%) | -$14.74M(+39.8%) |
| Jun 2013 | - | $2.02M(+36.1%) | -$10.55M(-16.1%) |
| Mar 2013 | - | $1.49M(-110.6%) | -$12.57M(-10.6%) |
| Dec 2012 | -$14.06M(>+9900.0%) | -$14.05M(<-9900.0%) | -$14.06M(-804.7%) |
| Sep 2012 | - | $0.00(-100.0%) | $2.00M(+0.1%) |
| Jun 2012 | - | -$1900.00(-62.0%) | $1.99M(<-9900.0%) |
| Mar 2012 | - | -$5000.00(-100.2%) | -$8600.00(+138.9%) |
| Dec 2011 | -$3600.00(+24.1%) | $2.00M(<-9900.0%) | -$3600.00(-99.8%) |
| Sep 2011 | - | -$2000.00(-99.9%) | -$2.01M(+0.1%) |
| Jun 2011 | - | -$2.00M(<-9900.0%) | -$2.01M(>+9900.0%) |
| Mar 2011 | - | $0.00(-100.0%) | -$2900.00(0.0%) |
| Dec 2010 | -$2900.00(+26.1%) | -$2900.00(<-9900.0%) | -$2900.00(+26.1%) |
| Sep 2010 | - | $0.00(0.0%) | -$2300.00(0.0%) |
| Jun 2010 | - | $0.00(-100.0%) | -$2300.00(0.0%) |
| Dec 2009 | -$2300.00(+76.9%) | -$2300.00(<-9900.0%) | -$2300.00(<-9900.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2008 | -$1300.00(-98.0%) | $0.00(0.0%) | -$1300.00(-88.4%) |
| Sep 2008 | - | $0.00(0.0%) | -$11.20K(-66.2%) |
| Jun 2008 | - | $0.00(-100.0%) | -$33.10K(-47.5%) |
| Mar 2008 | - | -$1300.00(-86.9%) | -$63.10K(-4.2%) |
| Dec 2007 | -$65.90K(+212.3%) | -$9900.00(-54.8%) | -$65.90K(+17.7%) |
| Sep 2007 | - | -$21.90K(-27.0%) | -$56.00K(+64.2%) |
| Jun 2007 | - | -$30.00K(+631.7%) | -$34.10K(+731.7%) |
| Mar 2007 | - | -$4100.00 | -$4100.00 |
| Dec 2006 | -$21.10K(+441.0%) | - | - |
| Dec 2005 | -$3900.00(+116.7%) | - | - |
| Dec 2004 | -$1800.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual CFI year-on-year change?
- What is Catalyst Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly CFI year-on-year change?
- What is Catalyst Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM CFI year-on-year change?
What is Catalyst Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of CPRX is -$556.00K
What is the all time high annual CFI for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual cash flow from investing activities is $37.23M
What is Catalyst Pharmaceuticals annual CFI year-on-year change?
Over the past year, CPRX annual cash flow from investing activities has changed by +$292.95M (+99.81%)
What is Catalyst Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of CPRX is $0.00
What is the all time high quarterly CFI for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly cash flow from investing activities is $31.66M
What is Catalyst Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, CPRX quarterly cash flow from investing activities has changed by +$199.00K (+100.00%)
What is Catalyst Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of CPRX is -$357.00K
What is the all time high TTM CFI for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM cash flow from investing activities is $41.71M
What is Catalyst Pharmaceuticals TTM CFI year-on-year change?
Over the past year, CPRX TTM cash flow from investing activities has changed by +$130.98M (+99.73%)